Is sclerostin antibody an effective agent for alveolar bone regeneration in animal models? A scoping review

• Autori principali: Venkitachalam Ramanarayanan (Autore), Jothi M Varghese (Autore), Madhurya N Kedlaya (Autore), Sunaina Banu (Autore), Lakshmi Puzhankara (Autore)
• Natura: Libro
• Pubblicazione: Cumhuriyet University, 2022-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Objectives The use of Sclerostin Antibody(Scl-Ab) as a bone anabolic agent has shown significant benefit in bone disorders in preclinical animal models and human clinical trials. Currently available evidence on the use of Scl-Ab in alveolar bone regeneration is limited to animal studies and hence th...